DigestRedComo funciona
Red
/
Empresas
Cu
No verificado

Curium

Sobre qué escribimos

Anuncios brevesFarmacéuticaGestión empresarial/Administración de EmpresasMedicina Salud Bienestar

18 Comunicados de prensa

Ver todos los comunicados de prensa
11/06/2026
Farmacéutica
Gestión empresarial/Administración de Empresas
Curium Group, PeptiDream and PDRadiopharma Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0
31/05/2026
Farmacéutica
Curium Announces a Strategic Investment of Over €32 million in Saclay, France
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0
26/02/2026
Farmacéutica
Medicina Salud Bienestar
Curium Announces Pharmacokinetics and Dosimetry Data for Investigational Lutetium-177 Zadavotide Guraxetan in Metastatic Castration-Resistant Prostate Cancer at ASCO GU 2026
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0
03/02/2026
Farmacéutica
Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of Lu-PSMA-I&T for Prostate Cancer in Japan
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0
07/01/2026
Farmacéutica
Medicina Salud Bienestar
Anuncios breves
Curium’s Investigational New Drug Application Accepted by Center for Drug Evaluation in China
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0
22/12/2025
Farmacéutica
Medicina Salud Bienestar
Anuncios breves
Curium Announces First Commercial Doses of PYLCLARI® for Patients with Prostate Cancer in Poland
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0
20/11/2025
Farmacéutica
CapVest recapitalizes Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0
19/11/2025
Farmacéutica
Gestión empresarial/Administración de Empresas
Medicina Salud Bienestar
Curium Announces First Commercial Doses of Diagnostic Radiopharmaceutical in Czech Republic and Slovakia for Patients with Prostate Cancer
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0
17/11/2025
Farmacéutica
Anuncios breves
Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0
14/10/2025
Farmacéutica
Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
Fuente
Curium
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0